NCT06613503 Effectiveness of the AI-Supporter in Reducing Urinary Tract Infections
| NCT ID | NCT06613503 |
| Status | Recruiting |
| Phase | — |
| Sponsor | China Medical University Hospital |
| Condition | Incontinence |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-07-22 |
| Primary Completion | 2025-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-07-22 with a primary completion date of 2025-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The "AI Supporter," an intelligent excretion management robot, leverages artificial intelligence-based vision recognition to autonomously detect and cleanse affected areas, followed by drying and changing the diaper, thereby reducing caregiver strain and enhancing care quality. This study aims to assess the efficacy of the "AI Supporter" in decreasing the incidence of urinary tract infections and incontinence-associated dermatitis among incontinent patients, in addition to exploring its cost-effectiveness. Adopting an experimental (two groups) and longitudinal design, this research utilizes both convenience and random sampling strategies. The study anticipates recruiting 60 female subjects who have been confined to bed for more than three months with urinary and/or fecal incontinence. Participants will intermittently use the AI Supporter over a 14-day period. Measurement tools include routine urine analysis.
Eligibility Criteria
Inclusion Criteria: * Participants must have been bedridden for at least 3 months and have urinary and/or fecal incontinence. * Female participants aged over 20 years old. * Participants must be capable of wearing the AI-supporter device during the study period. Exclusion Criteria: * Participants with severe skin conditions unrelated to incontinence. * Participants with current urinary tract infections or incontinence-associated dermatitis at the time of enrollment. * Participants who are unable to provide informed consent or have a legal representative to do so.
Contact & Investigator
Kwo-Chen Lee, ph.D
STUDY DIRECTOR
011+886+4+22053366#7102
Frequently Asked Questions
Who can join the NCT06613503 clinical trial?
This trial is open to female participants only, aged 20 Years or older, studying Incontinence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06613503 currently recruiting?
Yes, NCT06613503 is actively recruiting participants. Contact the research team at rubylee@mail.cmu.edu.tw for enrollment information.
Where is the NCT06613503 trial being conducted?
This trial is being conducted at Taichung, Taiwan.
Who is sponsoring the NCT06613503 clinical trial?
NCT06613503 is sponsored by China Medical University Hospital. The principal investigator is Kwo-Chen Lee, ph.D at 011+886+4+22053366#7102. The trial plans to enroll 60 participants.